Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2021

Pharma News, 2021

U.S. begins study on allergic reaction risk in Moderna, Pfizer vaccines
U.S. begins study on allergic reaction risk in Moderna, Pfizer vaccines
(Reuters) -The U.
Merck & Co. says adjuvant Keytruda hits main goal of late-stage RCC study
Merck & Co. says adjuvant Keytruda hits main goal of late-stage RCC study
Merck & Co.
FDA Approves Trodelvy®, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival
FDA Approves Trodelvy®, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival
FOSTER CITY, Calif.
More vaccine sites halt Johnson & Johnson shots after adverse reactions
More vaccine sites halt Johnson & Johnson shots after adverse reactions
RALEIGH, N.
Gene discovery suggests new treatment approach for liver cancer
Gene discovery suggests new treatment approach for liver cancer
In a comprehensive analysis of human gene activation data, researchers from the Centenary Institute have discovered that the dipeptidyl peptidase-4 (DPP4) gene family is strongly implicated in...
Researchers develop materials for oral delivery of insulin medication
Researchers develop materials for oral delivery of insulin medication
A revolutionary technology developed within the Trabolsi Research Group at NYU Abu Dhabi (NYUAD) could dramatically improve the well-being of diabetic patients through a simple and straightfor...
Paleopharmaceuticals from Baltic amber might fight drug-resistant infections
Paleopharmaceuticals from Baltic amber might fight drug-resistant infections
WASHINGTON, April 6, 2021 -- For centuries, people in Baltic nations have used ancient amber for medicinal purposes.
Artificial intelligence to explore the biomolecular world
Artificial intelligence to explore the biomolecular world
EPFL (Ecole Polytechnique Federale de Lausanne) scientists have developed AI-powered nanosensors that let researchers track various kinds of biological molecules without disturbing them.
FDA Issues Guidance on Generic Development and Submissions During Pandemic
FDA Issues Guidance on Generic Development and Submissions During Pandemic
The FDA released Q&A guidance yesterday on bioequivalence (BE) studies for generic drugs and abbreviated new drug application (ANDA) submissions during the COVID-19 pandemic.
J&J Bets Up to $780 Million on Cidara’s Universal Influenza Treatment
J&J Bets Up to $780 Million on Cidara’s Universal Influenza Treatment
Cidara Therapeutics inked a deal worth up to $780 million with Johnson & Johnson to develop and commercialize Cidara’s candidate CD388 for the prevention and treatment of seasonal and pandemic i...
Phase 1 clinical trial of WRAIR-developed COVID-19 vaccine begins
Phase 1 clinical trial of WRAIR-developed COVID-19 vaccine begins
SILVER SPRING, Md.
Supernus Announces FDA Approval of Qelbree™ (SPN-812) for the Treatment of ADHD
Supernus Announces FDA Approval of Qelbree™ (SPN-812) for the Treatment of ADHD
ROCKVILLE, Md.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand